CELLINK and Carcinotech partner to transform cancer drug development with 3D bioprinting
Carcinotech and 3D bioprinting firm CELLINK have announced a partnership to accelerate cancer drug development with 3D bioprinted tumor models.
LATEST NEWS
- 02 / 25 : Croom Medical breaks ground on ACOT orthopaedic manufacturing and R&D facility in Limerick
- 02 / 21 : Stratasys Introduces Dental Anatomical Model Preset for Education and Clinical Training
- 02 / 20 : 3D printed pool makes a big splash in Australia Construction 3D Printing
- 02 / 19 : Materialise adds custom-made PEEK implants to cranio-maxillofacial portfolio
- 02 / 17 : MIT Introduces MagMix to Reduce Cell Settling in 3D Bioprinting, Addresses Key Limitation
2026-02-25